Elsevier Inc.

SHERPA: Unknown

People

  1. Cheung
    Cheung
  2. Kushner
    Kushner
  3. Wolden
    Wolden
  4. Modak
    Modak
  5. La Quaglia
    La Quaglia
  6. Kramer
    Kramer
  7. Basu
    Basu
  8. Abramson-Squire
    Abramson-Squire
  9. Alektiar
    Alektiar
  10. Gerstle
    Gerstle

Groups

  1. Neuroblastoma Service (55)
  2. Pediatrics, Department of (55)
  3. Tow Center for Developmental Oncology (TCDO) (38)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (37)
  5. GSK Faculty (37)
  6. Center for Hematologic Malignancies (32)
  7. Pediatric Leukemia (30)
  8. Radiation Oncology, Department of (24)
  9. Survivorship Research (24)
  10. Center for Molecular Imaging and Biotechnology (23)
Search Within
  1. "Neuroblastoma Service"
Formats
  1. Journal Article (27)
  2. Meeting Abstract (20)
  3. Book Section (4)
  4. Conference Paper (3)
  5. Review (1)
Groups
  1. Neuroblastoma Service (55)
  2. Pediatrics, Department of (55)
  3. Tow Center for Developmental Oncology (TCDO) (38)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (37)
  5. GSK Faculty (37)
  6. Center for Hematologic Malignancies (32)

More Groups

People
  1. Nai-Kong Cheung (37)
  2. Brian Kushner (33)
  3. Suzanne Wolden (24)
  4. Shakeel Modak (23)
  5. Michael La Quaglia (20)
  6. Kim Kramer (14)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2022 (2)
  4. 2020 (3)
  5. 2019 (3)
  6. 2018 (4)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (26)
  2. European Journal of Cancer (10)
  3. Seminars in Oncology (3)
  4. Cancer Treatment Reviews (2)
  5. Pharmacology & Therapeutics (2)
  6. Abeloff’s Clinical Oncology. 6th ed (1)

More Publications

Results (55)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions
    Journal Article

    Desai, A. V.; Bagchi, A.; Armstrong, A. E.; van Tilburg, C. M.; Basu, E. M.; Robinson, G. W.; Wang, H.; Casanova, M.; André, N.; Campbell-Hewson, Q.; more...
    European Journal of Cancer (2025)

    Fulltext@MSK | Save
  • Reduced-dose radiation therapy for high-risk neuroblastoma: Results from a prospective clinical trial
    Meeting Abstract

    Jackson, C.; Modak, S.; LaQuaglia, M. P.; Kushner, B.; Gerstle, J. T.; Basu, E.; Cheung, N. K.; Iglesias-Cardenas, F.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Intraoperative radiation therapy for relapsed or refractory high-risk neuroblastoma: A 27-year experience
    Journal Article

    Conte, B.; Casey, D. L.; Tringale, K. R.; Honeyman, J.; Narayan, N. J. C.; LaQuaglia, M. P.; Gerstle, J. T.; Modak, S.; Kushner, B. H.; Kramer, K.; more...
    Practical Radiation Oncology (2024)

    Fulltext@MSK | Save
  • A radiohapten capture system for CAR T cells that tracks them in vivo and improves efficacy
    Meeting Abstract

    Kurtz, K.; Eibler, L.; Dacek, M.; Carter, L.; Cheal, S.; Veach, D.; Qureshy, S.; Han, J.; Reynaud, E.; Verma, S.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Bispecific antibodies for the treatment of neuroblastoma
    Review

    Espinosa-Cotton, M.; Cheung, N. K. V.
    Pharmacology & Therapeutics (2022)

    Fulltext@MSK | Save
  • Therapeutic antibodies and immunologic conjugates
    Book Section

    Dobrenkov, K.; Cheung, N. K. V.
    In Niederhuber, J. E.; Armitage, J. O.; Kastan, M. B.; Doroshow, J. H.; Tepper, J. E. (Eds.) Abeloff’s Clinical Oncology. 6th ed (2020)

    Fulltext@MSK | Save
  • Long-term survivors receive multimodality treatment of second central nervous system relapse in pediatric patients with neuroblastoma
    Meeting Abstract

    Tringale, K. R.; Kramer, K.; Luo, L.; Casey, D. L.; Kushner, B.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • TPX-0005 (Repotrectinib), a next-generation ALK/ROS1/NTRK1-3 inhibitor, has potent antiproliferative and anti-tumor activity as monotherapy and in combination with chemotherapy in neuroblastoma cell lines and pediatric patient derived xenograft models
    Meeting Abstract

    O'Donohue, T.; Ibáñez, G.; Mauguen, A.; Siddiquee, A.; Rosales, N.; Calder, P.; Ndengu, A.; Roberts, S.; Dela Cruz, F.; Kung, A.
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Immunotherapy for neuroblastoma
    Book Section

    Kudva, A.; Modak, S.
    In Ray, S. K. (Eds.) Neuroblastoma: Molecular Mechanisms and Therapeutic Interventions (2019)

    Fulltext@MSK | Save
  • Neuroblastoma: Pathology and genetics
    Book Section

    Cheung, N. K. V.; Lopez-Rodrigo, E.; Boffetta, P.; Hainaut, P. Encyclopedia of Cancer. 3rd ed (2019)

    Fulltext@MSK | Save